Close Menu

NEW YORK, Jan. 18 - Federal regulators have cleared Millennium Pharmaceuticals' proposed acquisition of COR Therapeutics, the companies announced on Friday.

The US Federal Trade Commission has ended the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 on Jan. 14, giving the deal the green light.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Oil made from gene-edited soybeans is already in use, according to the Associated Press.

USA Today reports that Department of Veterans Affairs is teaming up with Sanford Health to provide veterans with genetic testing.

Mother Jones reports there are few regulations overseeing the use of genetic genealogy by law enforcement.

In Science this week: analysis of ancient DNA recovered from Iberian populations, and more.